NSCLC
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who underwent thoracoscopic sublobar, lobar, compound lobe or pneumonectomy with or without mediastinal lymph node resection; 2. Postoperative pathological diagnosis of primary non-small cell lung cancer stage I, IIA or carcinoma in situ; 3. No chest pain before surgery and chest pain within 3 months after surgery; 4. Aged 18 to 85 years; 5. Voluntarily participate in clinical trials, sign informed consent, and be able to contact follow-up; 6. Only those who meet all the above conditions can be included in the study.
Exclusion criteria
Exclusion criteria: 1. Combined with serious primary diseases of the heart, brain, kidney and other serious diseases; 2. Mental patients; 3. Those who meet the diagnostic criteria for non-small cell lung cancer but have undergone surgery, radiotherapy, chemotherapy, targeted therapy and received traditional Chinese medicine within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate of pain improvement;Cough score;Quality of life score;TCM syndrome integral; | — |
Countries
China
Contacts
Peking University People's Hospital